Literature DB >> 27126544

Molecular mechanism of prion-like tau-induced neurodegeneration.

Alejandra D Alonso1, Cindy Beharry2, Christopher P Corbo3, Leah S Cohen2.   

Abstract

INTRODUCTION: Accumulation of hyperphosphorylated tau and the disruption of microtubules are correlated with synaptic loss and pathology of Alzheimer's disease (AD). Impaired cognitive function and pathology of AD is correlated with this lesion. This review looks at the mechanism of neurodegeneration, the prion-like behavior of tau in its interaction with normal MAPs in correlation with tau hyperphosphorylation.
METHODS: We reviewed our work in the field as well as current literature that pertains to tau phosphorylation and the biological effects.
RESULTS: Hyperphosphorylation of tau in AD, in vitro, in cells, or in animal models converts this protein into a prion-like protein that is able to propagate the altered conformation. DISCUSSION: These findings suggest that phosphorylation of tau is a critical event in neurodegeneration. The combination of phosphorylation sites can generate a gain of toxic function for tau. The mechanism of tau toxicity might involve not only the microtubule system but also interference with other cellular compartments such as the nucleus and the actin cytoskeleton.
Copyright © 2016 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Actin; Alzheimer; Microtubules; Neurodegeneration; Nuclear translocation; Tau; Tau phosphorylation

Mesh:

Substances:

Year:  2016        PMID: 27126544     DOI: 10.1016/j.jalz.2015.12.014

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  19 in total

1.  Neuron-to-Neuron Transfer of FUS in Drosophila Primary Neuronal Culture Is Enhanced by ALS-Associated Mutations.

Authors:  Sébastien Feuillette; Morgane Delarue; Gaëtan Riou; Anne-Lise Gaffuri; Jane Wu; Zsolt Lenkei; Olivier Boyer; Thierry Frébourg; Dominique Campion; Magalie Lecourtois
Journal:  J Mol Neurosci       Date:  2017-04-20       Impact factor: 3.444

2.  Targeting the HDAC2/HNF-4A/miR-101b/AMPK Pathway Rescues Tauopathy and Dendritic Abnormalities in Alzheimer's Disease.

Authors:  Dan Liu; Hui Tang; Xin-Yan Li; Man-Fei Deng; Na Wei; Xiong Wang; Ya-Fan Zhou; Ding-Qi Wang; Peng Fu; Jian-Zhi Wang; Sébastien S Hébert; Jian-Guo Chen; Youming Lu; Ling-Qiang Zhu
Journal:  Mol Ther       Date:  2017-02-13       Impact factor: 11.454

Review 3.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

4.  Probing Conformational Dynamics of Tau Protein by Hydrogen/Deuterium Exchange Mass Spectrometry.

Authors:  Richard Y-C Huang; Roxana E Iacob; Sethu Sankaranarayanan; Ling Yang; Michael Ahlijanian; Li Tao; Adrienne A Tymiak; Guodong Chen
Journal:  J Am Soc Mass Spectrom       Date:  2017-10-02       Impact factor: 3.109

Review 5.  Seeking a New Paradigm for Alzheimer's Disease: Considering the Roles of Inflammation, Blood-Brain Barrier Dysfunction, and Prion Disease.

Authors:  Mark E McCaulley; Kira A Grush
Journal:  Int J Alzheimers Dis       Date:  2017-12-05

6.  Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer's disease hallmarks.

Authors:  Sven Reinhardt; Nicolai Stoye; Mathias Luderer; Falk Kiefer; Ulrich Schmitt; Klaus Lieb; Kristina Endres
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

7.  Tau Pathology Promotes the Reorganization of the Extracellular Matrix and Inhibits the Formation of Perineuronal Nets by Regulating the Expression and the Distribution of Hyaluronic Acid Synthases.

Authors:  Yin Li; Ze-Xu Li; Tan Jin; Zhan-You Wang; Pu Zhao
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 8.  Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease.

Authors:  Hui Li; Xiaobing Wang; Hongmei Yu; Jing Zhu; Hongtao Jin; Aiping Wang; Zhaogang Yang
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  Soluble Tau has devastating effects on the structural plasticity of hippocampal granule neurons.

Authors:  M Bolós; N Pallas-Bazarra; J Terreros-Roncal; J R Perea; J Jurado-Arjona; J Ávila; M Llorens-Martín
Journal:  Transl Psychiatry       Date:  2017-12-08       Impact factor: 6.222

Review 10.  Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability.

Authors:  Alejandra D Alonso; Leah S Cohen; Christopher Corbo; Viktoriya Morozova; Abdeslem ElIdrissi; Greg Phillips; Frida E Kleiman
Journal:  Front Cell Neurosci       Date:  2018-10-09       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.